AINewsnow

AI drug development startup Pathos AI closes $237M investment

Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers. Pathos’ investor roster includes big names such as AstraZeneca plc, NE…

Read the full story at SiliconANGLE AI ↗

Timeline · 1 report

  1. 2026-10-23 20:02 · SiliconANGLE AI
    AI drug development startup Pathos AI closes $237M investment

More stories

  1. Securing our frontier model training environment — OpenAI News
  2. Kimi K3.1 Pro and Kimi K3.1 Pro Highspeed are available now in AI Gateway — Vercel Blog
  3. Anthropic Joins the A.I. Agent Race With Claude Duet — New York Times Technology
  4. Stop guessing auto scaling targets for TTS on Amazon SageMaker AI — AWS Machine Learning Blog
  5. At MIT, Martha Minow speaks on sustaining democracy, both by using and overcoming AI — MIT News AI
  6. Why Google CEO Sundar Pichai thinks asking 'how much code AI writes' is the wrong question — Mint AI
  7. Q&A: How AI came to model the “messy” human mind — MIT News AI
  8. LitPivot: Developing research ideas through dynamic contextualization within the literature landscape — Allen Institute for AI (Ai2)

Get the daily brief of stories like this at 6:30 every morning →